InsidersTradesSigma
Track the HERON THERAPEUTICS, INC. /DE/ share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €63.9m. The latest transaction was disclosed on 10 August 2026 (Levée d'options). Among the most active insiders: Duarte Ira. All data is openly available.
128
Insider Decl.
n/a
Thresholds
€9m
7 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate HERON THERAPEUTICS, INC. /DE/ Hold (neutral), based on 3 analysts. Average price target: US$7.00.
25Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,395 of 29,063 companies
27.6
score / 100
Value6
Quality49
FCF yld-45%
Earn yld-33%
EV/EBITDA·
ROE·
Gross mgn73%
Net mgn-13%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 August 2026
Declarations128 total
31,250 sharesCommon StockSEC:0001193125-26-341528:0
8,888 shares@ US$0.500.0048% mcap100.0% of flowCommon StockSEC:0001193125-26-341528:1
3,326 shares@ US$0.500.0018% mcap2.0% of flowCommon StockSEC:0001193125-26-329720:3
3,326 shares@ US$0.500.0018% mcap2.0% of flowCommon StockSEC:0001193125-26-329804:3
11,694 sharesCommon StockSEC:0001193125-26-329720:2
11,769 sharesCommon StockSEC:0001193125-26-329848:0
50,021 sharesCommon StockSEC:0001193125-26-329694:0
34,789 sharesCommon StockSEC:0001193125-26-329694:1
13,535 sharesCommon StockSEC:0001193125-26-329720:0
11,769 sharesCommon StockSEC:0001193125-26-329804:0
11,694 sharesCommon StockSEC:0001193125-26-329804:2
3,850 shares@ US$0.500.0021% mcap2.3% of flowCommon StockSEC:0001193125-26-329720:1
3,348 shares@ US$0.500.0018% mcap2.0% of flowCommon StockSEC:0001193125-26-329804:1
1,101 shares@ US$0.470.0006% mcap0.7% of flowCommon StockSEC:0001193125-26-308922:1
13,797 sharesCommon StockSEC:0001193125-26-308958:0
3,874 sharesCommon StockSEC:0001193125-26-308922:0
3,874 sharesCommon StockSEC:0001193125-26-308887:0
1,101 shares@ US$0.470.0006% mcap0.6% of flowCommon StockSEC:0001193125-26-308887:1
12,500 sharesCommon StockSEC:0001193125-26-273552:0
3,555 sharesCommon StockSEC:0001193125-26-273552:1
13,797 sharesCommon StockSEC:0001193125-26-165365:0
3,874 sharesCommon StockSEC:0001193125-26-165304:0
3,874 sharesCommon StockSEC:0001193125-26-165591:0
62,500 sharesCommon StockSEC:0001193125-26-144196:0
53,960 shares0Common StockSEC:0001193125-26-034632:0
25 of 128 declarations
Acerca de HERON THERAPEUTICS, INC. /DE/
HERON THERAPEUTICS, INC. es una empresa biofarmacéutica centrada en el desarrollo de tratamientos para el dolor y las náuseas. Cotiza en NASDAQ bajo el ticker HRTX.